5Griffin MR,Piper JM,Doughtory JR et al.Nonsteroidal antiinflammatory drug use and increase risk for peptic ulcer disease in elderly persons.Am Intern Med 1991,114:257-263.
6Whelton A. Nephrotoxicity of nonsteroidal anti-inflam-matory drugs: physiologic foundations and clinical implications. Am J Med, 1999, 106(5B): 13S.
7Kraus VB.Pathogenesis and treatment of osteoarthritis.Med Clinic North Am, 1997,81(1):85-112.
1Vane JR, Botting RM. Overview: the mechanism of action of anti-inflammatory drugs.//Vane JR, Botting RM,eds. Clinical significance and potential of selective COX-2 inhibitors [M]. London:William Harvey Press,1998:1-11.
2Crofford L J, Lipsky PE, Brooks P, et al. Basic biology and clinical application of specific cyclooxygenase-2 inhibitors [J] . Arthritis Rheum, 2000, 43 ( 1 ): 4.
3Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: Physiologic foundations and clinical implications [J] . Am J Med, 1999, 106(5B): 13S.
4Whelton A. Renal and related cardiovascular effects of conventional and COX-2-specific NSAIDs and nonNSAID analgesics [J] . Am J Ther, 2000, 7(2): 63-74.
5Griffin MR, Yared A, Ray WA. Nonsteroid antiinflammatory drugs and acute renal failure in elderly persons [J] . AmJEpidemiol, 2000, 151 (5): 488.
6WalfG, Porth J, Stabl RAK. Acute renal failure associated with rofecoxib [ J] . Ann Intern Med, 2000, 133(5): 394.
7Alkhuja S, Menkel RA, Alwarshetty M, et al. Celecoxib-induced nonoliguric acute renalfailure [ J] . Ann Pharmacother, 2002, 36 ( 1 ): 52.
8Ahmad SR, Kortepeter C, Brinker A, et al. Renal failure associated with the use ofcelecoxib and rofecoxib [J] .Drug Saf, 2002, 25 (7): 527.
